{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:42:47Z","timestamp":1789612967080,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.kint.2016.07.039","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T12:40:30Z","timestamp":1474634430000},"page":"86-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease"],"prefix":"10.1016","volume":"91","author":[{"given":"Toshifumi","family":"Sugatani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Agapova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alycia G.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut H.","family":"Malluche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Faugere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Hruska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2016.07.039_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00467-009-1337-0","article-title":"Cardiovascular risk in chronic kidney disease (CKD), the CKD-mineral bone disorder (CKD-MBD)","volume":"25","author":"Hruska","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2016.07.039_bib2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.07.039_bib3","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Seventh Edition","article-title":"The chronic kidney disease mineral bone disorder (CKD-MBD)","author":"Hruska","year":"2008"},{"key":"10.1016\/j.kint.2016.07.039_bib4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1 and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.kint.2016.07.039_bib5","first-page":"36A","article-title":"Early chronic kidney disease (CKD) stimulates vascular calcification (VC) and decreased bone formation rates prior to positive phosphate balance","volume":"20","author":"Fang","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.07.039_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.07.039_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification","volume":"85","author":"Fang","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.07.039_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.07.039_bib9","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","article-title":"CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder","volume":"25","author":"Fang","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.07.039_bib10","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/ndt\/gft234","article-title":"Disturbances of Wnt\/\u03b2-catenin pathway and energy metabolism in early CKD: effect of phosphate binders","volume":"28","author":"de Oliveira","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2016.07.039_bib11","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/\u03b2-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.07.039_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","article-title":"Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model","volume":"15","author":"Lund","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.07.039_bib13","doi-asserted-by":"crossref","first-page":"F431","DOI":"10.1152\/ajprenal.0009.2001","article-title":"A\u00a0role for Wnt-4 in renal fibrosis","volume":"282","author":"Surendran","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2016.07.039_bib14","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1681\/ASN.2004110949","article-title":"Wnt-dependent- \u03b2-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis","volume":"16","author":"Surendran","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.07.039_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.2372","article-title":"Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy","volume":"30","author":"Moe","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.07.039_bib16","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.kint.2016.02.002","article-title":"Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease","volume":"89","author":"Agapova","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.07.039_bib17","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1101\/gad.9.22.2808","article-title":"BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning","volume":"9","author":"Luo","year":"1995","journal-title":"Genes Dev"},{"key":"10.1016\/j.kint.2016.07.039_bib18","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.V12112392","article-title":"Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy","volume":"12","author":"Wang","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.07.039_bib19","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1046\/j.1523-1755.2003.00035.x","article-title":"Bone morphogenetic protein-7 (BMP-7), a novel therapy for diabetic nephropathy","volume":"63","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.07.039_bib20","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/01.ASN.0000068404.57780.DD","article-title":"BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure","volume":"14","author":"Davies","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.07.039_bib21","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1523-1755.2002.00258.x","article-title":"Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7","volume":"61","author":"Gonzalez","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.07.039_bib22","doi-asserted-by":"crossref","first-page":"e8198","DOI":"10.1371\/journal.pone.0008198","article-title":"ActRIIA and BMPRII type II BMP receptor subunits selectively required for Smad4-independent BMP7-evoked chemotaxis","volume":"4","author":"Perron","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2016.07.039_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12964-015-0104-z","article-title":"Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B","volume":"13","author":"Olsen","year":"2015","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.kint.2016.07.039_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bone.2015.07.027","article-title":"Determinants of bone strength and quality in diabetes mellitus in humans","volume":"82","author":"Farr","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.kint.2016.07.039_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S2213-8587(15)00283-1","article-title":"Type 2 diabetes and the skeleton: new insights into sweet bones","volume":"4","author":"Shanbhogue","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2016.07.039_bib26","doi-asserted-by":"crossref","first-page":"E762","DOI":"10.1152\/ajpendo.00501.2015","article-title":"High fat diet-induced skeletal inflammation inhibits Wnt signaling, Wnt ligand expression and bone formation in ApoE null mice","volume":"310","author":"Liu","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.07.039_bib27","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/jbmr.312","article-title":"Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids","volume":"26","author":"Sage","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.07.039_bib28","doi-asserted-by":"crossref","first-page":"19229","DOI":"10.1074\/jbc.M111.323600","article-title":"Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion","volume":"287","author":"Okayasu","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2016.07.039_bib29","doi-asserted-by":"crossref","first-page":"30427","DOI":"10.1074\/jbc.273.46.30427","article-title":"Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice","volume":"273","author":"Towler","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2016.07.039_bib30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1681\/ASN.2004100835","article-title":"Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome","volume":"16","author":"Davies","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.07.039_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1681\/ASN.2006050490","article-title":"Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy","volume":"18","author":"Mathew","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"suppl 113","key":"10.1016\/j.kint.2016.07.039_bib32","first-page":"S1","article-title":"KDIGO Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2016.07.039_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcb.10613","article-title":"Activin A stimulates IkappaB-alpha\/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors","volume":"90","author":"Sugatani","year":"2003","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.kint.2016.07.039_bib34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jbmr.2418","article-title":"Genomewide comprehensive analysis reveals critical cooperation between Smad and c-Fos in RANKL-induced osteoclastogenesis","volume":"30","author":"Omata","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.07.039_bib35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/endo.143.1.8580","article-title":"Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures","volume":"143","author":"Gaddy-Kurten","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2016.07.039_bib36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/jbmr.2120","article-title":"Role of TGF-\u03b2 in a mouse model of\u00a0high turnover renal osteodystrophy","volume":"29","author":"Liu","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.07.039_bib37","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1093\/emboj\/20.9.2254","article-title":"TGF-\u03b2-induced repression of CBFA1 by\u00a0Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation","volume":"20","author":"Alliston","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.kint.2016.07.039_bib38","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1073\/pnas.0711263105","article-title":"A\u00a0soluble activin type IIA receptor induces bone formation and improves skeletal integrity","volume":"105","author":"Pearsall","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2016.07.039_bib39","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/jbmr.485","article-title":"The pathophysiology of early-stage chronic kidney disease\u2013mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat","volume":"26","author":"Moe","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.07.039_bib40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ncb2022","article-title":"TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling","volume":"12","author":"Qiu","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.kint.2016.07.039_bib41","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.bone.2010.01.370","article-title":"A\u00a0soluble activin receptor type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys","volume":"46","author":"Lotinun","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.kint.2016.07.039_bib42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1242\/jcs.157834","article-title":"Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures","volume":"128","author":"Fowler","year":"2015","journal-title":"J\u00a0Cell Sci"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816304252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816304252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T02:42:15Z","timestamp":1657334535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253816304252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0085253816304252"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2016.07.039","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2016.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}